ROHTO is an Osaka-based Japanese healthcare and pharmaceutical company that invests as a corporate strategic investor. It is relevant for early-stage health-related startups with strategic fit across pharmaceuticals, eye care, skincare, medical devices, biotechnology, wellness, fertility and AI-enabled healthcare, and invests in Israel. Founders building in HealthTech, Life Sciences, Beauty, Women & FemTech or adjacent medical innovation may be a fit when there is clear corporate alignment.